Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors
ConclusionIrAEs, especially in skin, endocrine organ or gastrointestinal tract, triggered by ICIs indicate significant survival benefits.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Databases & Libraries | Gastroenterology | Immunotherapy | Liver | Skin | Statistics | Study | Urology & Nephrology